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doi:10.1016/j.jtcvs.2003.11.014TPlasma protein loss from prolonged chest tube drainage in pediatric patients aftersurgery can cause hypoalbuminemia and low levels of antithrombin (AT) III andimmunoglobulins (Igs). We report 5 cases of hypothyroidism possibly secondary toloss of thyroid binding globulin from prolonged chest tube drainage.
Clinical Summary
Patient 1, a 3.23-kg girl born with pulmonary and aortic stenosis, atrial septal defect (ASD),
and ventricular septal defect (VSD), underwent aortic and pulmonary valvotomies, ASD
closure, and patent ductus arteriosus ligation on day of life (DOL) 2. Chest tube drainage was
greater than 100 mL/d until postoperative day (POD) 108. To decrease lymphatic drainage,
thoracic duct ligation was performed on POD 33, and somatostatin (7 g · kg · d) was
administered on PODs 37 to 41. Thyroid function on newborn screening was normal. On
POD 8, the thyroid stimulating hormone (TSH) level was 15.18 mU/L (normal value 0.4-5.0
mU/L), and the free thyroxine level was 0.95 ng/dL (normal value 0.9-2.6 ng/dL). TSH levels
decreased to 8.57 mU/L by POD 39 (free thyroxine level 1.39 ng/dL) and 4.08 mU/L by POD
95 (free thyroxine level 0.72 ng/dL). Because the levels of serum IgG and ATIII were low,
the patient received serial intravenous (IV) Ig and ATIII replacement while chest tubes were
present. The patient died on POD 108 from acute renal failure and sepsis.
Patient 2, a 3.56-kg boy born with D-transposition of the great arteries, ASD, and VSD,
underwent complete repair on DOL 4. Chest tube output greater than 100 mL/day occurred
until POD 111. To decrease lymphatic drainage, the thoracic duct was ligated on POD 81, and
he received somatostatin (5-10 g · kg · d) on PODs 43 to 47. Peritoneal dialysis was initiated
on POD 14 for renal failure and was continued until POD 143. On POD 63, the TSH level
was 4.27 mU/L, and the free thyroxine level was 0.91 ng/dL. On POD 86, the TSH level was
6.85 mU/L, and the triiodothyronine level was 104 ng/dL (normal 85-250 ng/dL). Synthroid
therapy of 30 g/d was administered IV on PODs 97 to 143. The TSH level was 0.44 mU/L
on POD 105. Because the levels of IgG and ATIII were low, the patient received serial IVIg
and ATIII replacement. The patient died on POD 143 from xanthomonas peritonitis.
Patient 3, a 2.95-kg girl born with total anomalous pulmonary venous connection and
ASD, underwent complete repair on DOL 2. Chest tube output was greater than 100 mL/d
until POD 58. She underwent thoracic duct ligation on POD 29 to decrease lymphatic
drainage and had peritoneal dialysis on PODs 33 to 47 for renal failure. The TSH level was
1.02 mU/L (free thyroxine 1.19 ng/dL) on POD 9, and the free thyroxine level was 1.08 ng/dL
on POD 24. The TSH level was 5.41 mU/L (free thyroxine 0.5 ng/dL) on POD 43, and the
TSH level was 8.24 mU/L on POD 45. Synthroid therapy at 25 g/d enterally was initiated
on POD 45 and continued until POD 170. TSH levels ranged from 1.01 to 3.34 mU/L, and
free thyroxine levels ranged from 0.67 to 2.88 ng/dL while thyroid hormone was adminis-
tered. On POD 177, the TSH level was 3.56 mU/L, and the free thyroxine level was 0.87
ng/dL. Because the levels of ATIII and serum IgG were low, the patient received serial fresh
frozen plasma and IVIg replacement until the chest tubes were removed. The patient survived
and has not required any subsequent thyroid hormone supplementation.
Patient 4, a 4.45-kg girl born with hypoplastic right ventricle, ASD, VSD, and small
tricuspid valve, underwent VSD closure and ASD snare on DOL 123. Chest tube output was
greater than 100 mL/d until POD 58. To decrease lymphatic drainage, thoracic duct ligation
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were low, the patient received serial ATIII and IVIg replacement
until the chest tubes were removed. The TSH level was 3.74 mU/L
(free thyroxine 0.84 ng/dL) on POD 8, and the TSH level was 0.6
mU/L (free thyroxine 0.72 ng/dL) on POD 17. Synthroid therapy
at 25 g/d enterally was initiated on POD 17 and continued until
POD 114. While the patient was receiving thyroid hormone re-
placement, TSH levels ranged from 0.61 to 3.63 mU/L and free
thyroxine levels ranged from 0.84 to 1.77. After discontinuation of
thyroid hormone replacement, TSH levels have ranged from 3.47
to 7.42 mU/L, and free thyroxine levels have ranged from 1.65 to
2.11 ng/dL. The last measurement of thyroid hormone levels on
POD 184 showed a TSH level of 4.23 mU/L and a free thyroxine
level of 1.70 ng/dL. The patient survived and has not required any
subsequent thyroid hormone supplementation.
Patient 5, a 2.83-kg term boy born with DiGeorge syndrome,
Tetralogy of Fallot, and absent pulmonary valve, underwent Te-
tralogy of Fallot repair and placement of a pulmonary valve
allograft on DOL 15. At the time of surgery, he was found to have
a large chylous effusion. Chest tube output was greater than 100
mL/d until POD 24. To decrease lymphatic drainage, thoracic duct
ligation was performed on POD 18. Newborn screening was per-
formed before 24 hours of life, and the TSH level was 53.3 mU/L.
On POD 4, the TSH level was 19.32 mU/L and the free thyroxine
level was 0.92 ng/dL. Synthroid therapy at 25 g/d either IV or
enterally was initiated on POD 5 and continued until death oc-
curred on POD 56 from renal and respiratory failure. Because the
levels of ATIII were low, the patient received serial fresh frozen
plasma replacement.
Discussion
Prolonged chest tube drainage can be an important issue after
pediatric cardiac surgery. Loss of clotting factors such as ATIII in
the effluent can lead to hypercoagulability and thrombosis.1 Loss
of Ig can lead to increased risk of infection and has been reported
in pediatric patients after cardiac surgery.2 We report here for the
first time that thyroid function seems to be adversely affected by
prolonged chest tube drainage.
In our case series, large amounts of chest tube output (100
TABLE 1. Serum protein levels before replacement
Patient
number
TSH before
synthroid
replacement
(mU/L)
Free thyroxin
before
synthroid
replacement
(ng/dL)
1 NA NA
2 6.84 (87) 0.91 (63)
3 8.24 (45) 0.50 (43)
4 0.60 (17) 0.72 (17)
5 19.32 (4) 0.92 (4)
IVIg, Intravenous immunoglobulin; TSH, thyroid stimulating hormone; AT, a
postoperatively. Normal values: TSH (0.4 –5.0 mU/L); free thyroxine (0.9 –2.mL · kg · d) for a sustained period of time (10 days) likely led
1510 The Journal of Thoracic and Cardiovascular Surgery ● Mato deficits of ATIII, IgG, and thyroid hormone secondary to the
loss of thyroid-binding globulin. In our patient population, ATIII
deficiency occurred in all 5 patients and IgG deficiency occurred in
4 patients (patients 1-4). On average, ATIII deficiency developed
on POD 11, IgG deficiency occurred on POD 15, and clinical
evidence of hypothyroidism was evident on POD 31 (Table 1).
Transient secondary hypothyroidism is well described in pediatric
patients after cardiac surgery and is thought to be secondary to
suppression of the hypothalamic-pituitary-thyroid axis secondary
to critical illness with resolution within 1 week postoperatively.3
Except for possibly patient 4, our patients developed thyroid
dysfunction through a different mechanism because they presented
with elevated TSH levels and required therapy until death or until
well after removal of their chest tubes. The condition is not
permanent. All of the survivors did not require thyroid hormone
replacement after its initial discontinuation, and patient 1 recov-
ered without treatment. The development of hypothyroidism post-
operatively may be exacerbated by neonatal hypothyroidism. Pa-
tient 5 did have a borderline elevated TSH level (53.3 mU/L) on
newborn screening, which was performed before 24 hours of life
and not repeated. Patient 5 also had a large chylous effusion found
perioperatively, which may have been congenital. A correlation
between congenital hypothyroidism and pericardial effusion has
been previously reported.4
A number of postoperative factors, including the use of peri-
toneal dialysis, thoracic duct ligation, albumin or fresh frozen
plasma replacement, and somatostatin to decrease lymphatic drain-
age, may have affected the course of the development of postop-
erative hypothyroidism and need to be further analyzed in a
controlled fashion in future studies. The removal of peritoneal fluid
by dialysis may have contributed to the development of hypothy-
roidism in patients 2 and 3. The use of somatostatin in patients 1
and 2 to decrease chest tube output had no discernible effect on
thyroid function.
The development of hypothyroidism in the patients in our case
series was probably secondary to loss of thyroid-binding globulin
in chest tube output. This mechanism is similar to what has been
reported in patients with congenital nephrotic syndrome in whom
ATIII level before
replacement (%)
IgG level before
IVIg replacement
(mg/dL)
68 (14) 46 (8)
39 (25) 95 (31)
60 (9) 274 (15)
38 (8) 307 (8)
37 (4) NA
ombin; Ig, immunoglobulin; NA, not available. Parentheses delineate days
L); ATIII chromogenic  90%; IgG (240 – 870 mg/dL).e
ntithr
6 ng/dresolution of clinical hypothyroidism has been reported after bi-
y 2004
Brief Communicationslateral nephrectomy.5 To show this decisively, future studies
should quantitate the amount of thyroid-binding globulin in pleural
fluid.
Conclusion
When chest tube drainage leads to loss of Ig and ATIII, it is
important to document that thyroid function is normal. Although
the mechanism by which hypothyroidism occurs is not conclu-
sively proven, thyroid hormone replacement may be necessary in
instances in which prolonged chest tube drainage occurs.The Journal of ThoracicReferences
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A plea for decortication
Ce´dric Vallet,a Edgardo Pezzetta,a Genevie`ve Nicolet-Chatelin,b Zihad El Lamaa,b
Olivier Martinet,a and Hans-Beat Ris,a Lausanne, SwitzerlandActinomycosis is a rare infectious disease caused byActinomyces species, a genus of anaerobic gram-pos-itive bacillus. Actinomyces organisms are saprophytesof the human digestive tract and are very sensitive to
penicillin. Thoracic actinomycosis represents 15% to 20% of cas-
es1-4 with pleural effusion in only 20% of intrathoracic affec-
tion.1,4,5 The usual clinical picture is that of a pleural effusion or
pleural empyema together with a parenchymatous infection. We
report a case of pleural effusion caused by Actinomyces meyeri
without pulmonary involvement that failed to respond to chest tube
drainage and antibiotherapy.
Clinical Summary
A 64-year-old woman was admitted with a history of fever and a
dry cough associated with asthenia, weight loss, and exertional
dyspnea. There was no previous medical history except for smok-
ing and alcohol abuse. Laboratory studies showed a hemoglobin
value of 9.9 g/100 mL, a hematocrit value of 25%, a leukocyte
count of 13,200/mm3, and a sedimentation rate of greater than 120
mm/h. Hemocultures were sterile, and the result of an HIV test was
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showed a massive left pleural
effusion (Figure 1). Chest
tube drainage was performed,
and this revealed a purulent
effusion. A meyeri was iden-
tified after culture of the pleu-
ral effusion. Despite treat-
ment with intravenous penicillin (20 Mio IU/d), a loculated pleural
effusion developed. Chest computed tomography (CT) demon-
strated thickening and enhancement of the parietal pleura and
confirmed loculation of pleural effusion and left lower lobe atel-
ectasis (Figure 2). Bronchial carcinoma was excluded by means of
bronchoscopy and transbronchial biopsy of the left lower lobe.
Pulmonary function testing revealed moderated obstruction and an
important restriction, with a forced expiratory volume in 1 second
of 1.04 L (47% of predicted value), a forced vital capacity of 1.72
L (66% of predicted value), and a total lung capacity of 3.58 L
(72% of predicted value). The patient remained febrile without
clinical improvement and complained of pain at the site of previ-
ous drainage. A stage III empyema was diagnosed, and an oper-
ation was performed.
At thoracotomy, we found a pleurosubcutaneous fistula at the
site of thoracic drainage mimicking an empyema necessitatis. The
parietal and visceral pleura were thickened and adherent to adja-
cent structures, as usually seen in advanced mesothelioma. Decor-
tication was performed with resection of the sinus tract, including
the sixth rib and its interspace. Microbiologic examination of the
pleura was performed, and A meyeri was found in the pleural
loculations filled with putrid liquid. The patient presented no
postoperative complication and was discharged after 16 days. An
oral penicillin regimen was prescribed for 6 months. Clinical and
radiologic evolutions were favorable, with minimal pleural sequel-
lae on chest radiography. Functional evaluation at 6 months after
Dr Valletthe operation revealed a forced e
and Cardiovascular Surgery ●xpiratory volume in 1 second of
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